Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Cell Reports|January 9, 2020
The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral TargetWenjie Wang, Woo-Jin Shin, Bojie Zhang, et al.Cell & Bioscience|September 5, 2024
Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19Dat P Ha, Woo-Jin Shin, Ze Liu, et al.Journal of Medicinal Chemistry|January 22, 2013
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitorsEnguang Feng, Woo-Jin Shin, Xuelian Zhu, et al.NPJ Vaccines|November 25, 2025
A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccinationInho Cha, Yumiko Yamada, Dokyun Kim, et al.European Journal of Medicinal Chemistry|July 17, 2012
Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activitiesDeju Ye, Woo-Jin Shin, Ning Li, et al.Nature Microbiology|December 12, 2018
Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesisSu-Jin Park, Young-Il Kim, Angela Park, et al.Nature Microbiology|January 9, 2019
Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesisYounho Choi, Su-Jin Park, Yinyan Sun, et al.Mbio|March 28, 2022
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8Xin Wu, Tian Xia, Woo-Jin Shin, et al.Journal of Medicinal Chemistry|August 4, 2021
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)Sang Hoon Han, Christopher M Goins, Tarun Arya, et al.Mbio|May 24, 2020
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in FerretsSu-Jin Park, Kwang-Min Yu, Young-Il Kim, et al.Pageof 8